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The nondiphtheriae corynebacteria are uncommon but
increasingly recognized as agents of endocarditis in
patients with underlying structural heart disease or pros-
thetic valves. We describe three cases of nosocomial
endocarditis caused by nondiphtheriae corynebacteria,
including the first reported case of Corynebacterium amy-
colatum endocarditis. These all occurred in association
with indwelling intravascular devices.
he nondiphtheriae corynebacteria, major components of
the normal flora of human skin and mucous membranes,
are commonly isolated from clinical specimens. As such, they
are frequently dismissed as contaminants. Recently, however,
the microbiologic classification of this group of organisms and
their role in clinical disease are being more clearly defined (1).
In particular, Corynebacterium amycolatum, which was first
described in 1988 (2), is becoming widely recognized as an
important pathogen, although it has been underreported in part
because of its misidentification as C. xerosis (3,4), an estab-
lished human pathogen. 
These organisms are causes of community-acquired
endocarditis in patients who have underlying structural heart
disease or are immunocompromised, as well as of prosthetic-
valve endocarditis. Cases in previously healthy patients are
rarely described (5,6). Hospital-acquired bacterial endocarditis
accounts for 7.5% to 29% of cases of endocarditis in tertiary-
care hospitals and is strongly associated with infection of ind-
welling intravascular lines (7). Common causative organisms
include  Staphylococcus aureus, enterococci, and coagulase–
negative staphylococci.  Corynebacterium species are rarely
reported as agents of hospital-acquired endocarditis.
We describe three cases of endocarditis caused by three
different species of corynebacteria in our hospital within an 18-
month period, all associated with indwelling intravascular
devices (IID). These accounted for 3 of 10 cases of hospital-
acquired endocarditis identified during this period and include
the first reported case of endocarditis caused by C. amycola-
tum. Two of the  Corynebacterium species were resistant to
multiple antibiotics. These cases highlight the importance of
the nondiphtheriae corynebacteria as emerging multiresistant
nosocomial pathogens in the growing population of patients
with IID.
Case Reports
Case 1
A 74-year-old woman was hospitalized with a diagnosis of
antineutrophil cytoplasmic antibody (ANCA)-positive vasculi-
tis. Her treatment included daily plasma exchanges via a right
internal jugular vascular catheter that was placed on the 5th
hospital day. On day 21 of admission, she had a low-grade
fever that resolved after removal of the catheter, the tip of
which produced a culture of diphtheroids. Blood cultures were
sterile. 
The patient was discharged after 1 month but was readmit-
ted 4 weeks later for control of vasculitis. On admission she
was anemic (hemoglobin 7.0 g/dL) and had persistent micro-
scopic hematuria and elevated C-reactive protein. She had no
new vasculitic manifestations and, as previously, a grade II
systolic murmur was noted at the left sternal edge. She had a
fever of 38°C 48 hours after admission. Four sets of blood cul-
tures were positive for C. amycolatum (Table 1). Transesoph-
ageal echocardiogram (TOE) showed a large mobile vegetation
on the mitral valve, with prolapse and mild to moderate mitral
regurgitation. A transthoracic echocardiogram on her previous
admission had shown no mitral valve abnormality. A combina-
tion of intravenous vancomycin and oral rifampicin was begun,
and the fever resolved within 48 hours. The patient refused sur-
gical intervention, and dual antibiotic therapy was continued
indefinitely. A follow-up TOE at 15 months showed improve-
ment in mitral valve features and no vegetations. The antibiot-
ics were stopped after 16 months, and 5 months later the
patient had no clinical evidence of disease recurrence.
Case 2 
A 69-year-old woman with hemodialysis-dependent
chronic renal failure secondary to ANCA-positive vasculitis
was admitted after acute thrombosis of a GoreTex dialysis fis-
tula in her left arm. She had required temporary vascular
access for hemodialysis for the preceding 12 days. On exami-
nation she was unwell and feverish. She had a grade I systolic
murmur over the cardiac apex; no previous echocardiogram
was available. Two sets of blood cultures grew C. striatum
(Table 1), as did the tip of her vascular catheter on removal. A
TOE revealed a large vegetation on her mitral valve. Because
of penicillin allergy, intravenous vancomycin and oral rifampi-
cin were begun. The prosthetic arteriovenous fistula could not
be removed completely, although it was considered a potential
reservoir of infection. The patient had a mitral valve replace-
ment 22 days into medical therapy, on the 29th hospital day.
Her valve was completely destroyed, but on  culture was sterile.
Antibiotics were continued for another 15 days; however, the
patient had postoperative complications and died 4 weeks later.
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Case 3
A 53-year-old man underwent mitral valve replacement
with a Starr Edwards metal valve. His postoperative course
was complicated by acute renal failure, for which he required
temporary hemodialysis by vascular catheter for 36 days. The
maximum time a single line was in place was 13 days. Cultures
of four vascular catheter tips after their removal grew both
diphtheroids and coagulase-negative staphylococci, which
were considered to be normal skin flora. During this time, a
low-grade fever developed that resolved after a change of lines.
Blood cultures remained sterile. Serial echocardiograms over
the following 2 weeks, however, showed a worsening para-
prosthetic leak. Subsequently, five sets of blood cultures grew
C. jeikeium (Table 1). The patient completed 6 weeks of intra-
venous vancomycin and oral rifampicin for prosthetic valve
endocarditis and was well on discharge. At follow-up, TOE
studies showed no further increase in the paraprosthetic leak,
and the patient had no clinical evidence of relapse of infection.
He died 7 months later from noninfective causes.
Discussion 
Interest in the taxonomy of the nondiphtheriae corynebac-
teria has increased, with a resultant reclassification of earlier
defined taxa and discovery of new pathogens in the group
(1,8). One of the more commonly reported human infections
with these organisms is infectious endocarditis. Since 1966,
several case reports and reviews have described 191 cases of
nondiphtheriae corynebacterial endocarditis on both prosthetic
and native valves. In only six (3.1%) of these cases was associ-
ation with an indwelling intravascular device specifically doc-
umented: two patients in association with chronic hemodialysis
(6), one case attributed to an infected permanent pacemaker
wire (9), two in connection with ventriculo-peritoneal shunts
(6), and one in association with a ventriculo-atrial shunt (10).
Of reports pertaining to hospital-acquired endocarditis in par-
ticular, in four case series totaling 80 cases, Corynebacterium
species were not identified as causative agents (7,11-13). In
another series, Corynebacterium species accounted for 1 (3.3%)
of 30 cases (14), this case occurring postcardiac catheterization.
A further series of 14 cases of hospital-acquired endocarditis
describes 3 (21.4%) cases due to coryneform species but gives
no species identification or source of infection (15).
We have described three cases of nondiphtheriae coryne-
bacterial nosocomial endocarditis associated with IID, all
occurring in a single hospital, accounting for one third of 10
cases occurring in an 18-month period. These cases include the
first reported case of endocarditis caused by C. amycolatum.
Of the remaining seven cases, two were due to methicillin-
resistant S. aureus and five to methicillin-sensitive S. aureus.
Since Lehmann and Neumann proposed in 1896 that bacte-
ria morphologically resembling the diphtheria bacillus be
incorporated with it into the genus Corynebacterium, the clas-
sification of the coryneform bacteria has been drastically
altered (8). This change has, in turn, increased the difficulty of
identifying these organisms, as methods that reliably differenti-
ate related species, such as mycolic acid chromatography, gas
liquid chromatography, and molecular amplification tech-
niques, cannot easily be used in the routine laboratory setting.
During 1987 to 1995, 11 new Corynebacterium species were
described (1). Commercial identification systems need to be
updated to include those species relevant in human disease. C.
amycolatum has only recently been included in the updated
API Coryne database 2.0 (4), which, as illustrated by our case,
may still lead to misidentification if used alone. That there
have been no previous reports of  C. amycolatum causing
endocarditis may be due to its misidentification as other nonli-
pophilic fermentative corynebacteria species such as C. xerosis
and C. minutissimum (3,16), both of which are associated with
human disease.
Published material provides useful schema for differentiat-
ing C. amycolatum, C. minutissimum, and C. striatum by using
colonial morphology, carbohydrate assimilation tests, and sen-
sitivity to amoxycillin and the vibriostatic compound O/129, in
conjunction with the API Coryne and API 20NE systems (17).
Antibiotic sensitivity patterns may support identification, with
C. amycolatum and C. jeikeium generally resistant to multiple
antibiotics (18). In contrast, C. striatum, C. minutissimum, and
C. xerosis generally are sensitive to a wide range of antibiotics.
Funke et al. (1) have published guidelines for identifying
the coryneform bacteria, including simple phenotypic charac-
teristics but also recommending more complex chemotaxo-
nomic investigations and molecular genetic analysis if
Table 1. Patient characteristics, heart valve affected, source of Corynebacterium infection and organism cultured, London
Case 
Age(y)/
sex
Underlying disease 
process Site of endocarditis Associated IIDa Therapy Outcome
1 74/F ANCA +
vasculitis
Native mitral valve Vascular catheter
for HD
Vancomycin i.v. + oral 
rifampicin, 16 monthsb
Resolved at 21 months
postdiagnosis
2 69/F ANCA +
vasculitis
Native
mitral valve
Gortex AV fistula,
vascular catheter
for HD
Vancomycin i.v. + oral
rifampicin, 37 days;
mitral valve replacement
Died of unrelated 
causes 9 weeks after 
diagnosis 
3 53/M Postoperative
acute renal failure
Prosthetic mitral 
valve (Starr Edwards)
Vascular catheter
for HD CVC
Vancomycin i.v. + oral
rifampicin, 42 days
Died of unrelated
causes 8.5 months 
postdiagnosis
aIID = indwelling intravascular device; ANCA = anti-neutrophil cytoplasmic antibody; HD = hemodialysis; AV = arteriovenous; CVC = central venous catheter.
bPatient refused surgery and follow-up echocardiograms.Emerging Infectious Diseases  •  Vol. 8, No. 1, January 2002 99
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phenotypic characteristics do not differentiate between species.
These guidelines are intended to facilitate the establishment of
true disease associations of these organisms. In our experience,
morphologic features combined with antibiogram profiles and
the Coryne API allowed identification of two out of three
corynebacteria (Table 2). As the colonial morphology and the
Coryne API profile did not match in the isolate from Case 1,
the organism was sent to our reference laboratory, where iden-
tification as C. amycolatum was confirmed by gas liquid chro-
matography (Microbial Identification System, Microbial ID,
Newark, DE).
Treatment regimens described include penicillin alone,
beta-lactam antibiotics or erythromycin plus gentamicin, and
vancomycin. Our three patients all received dual therapy with
vancomycin and rifampicin. This combination has not previ-
ously been described but was effective in two of the three
patients (including the case of prosthetic valve endocarditis),
who were both free from infection at least 5 months after ces-
sation of therapy. In a review of 19 patients with prosthetic
valve endocarditis due to diphtheroids (19), 4 (57.1%) of 7
patients treated with antibiotics alone were reported as cured at
least 1 year posttreatment. Of 12 patients treated both medi-
cally and surgically, 7 (58.3%) were reported as having a
microbiologic cure (19).
This study highlights the importance of the nondiphtheriae
corynebacteria in severe human disease. Specifically, clini-
cians and microbiologists must be aware of the potential risk
factors for nondiphtheriae corynebacterial endocarditis in the
hospital setting and the danger of overlooking positive long-
line tip cultures as normal skin flora or contaminants. Stringent
identification of clinical isolates will be required to define the
role of the nondiphtheriae corynebacteria in human disease.
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Table 2. Identification and antibiograms of the Corynebacteria species in three cases of endocarditis, London
Organism: gram-positive rod, 
nonmotile, catalase positive Colonial morphology Further identification
Antibiotic sensitivity pattern (Stokes plate)
Sensitive  Resistant 
Corynebacterium amycolatum Case 1 Dry, graya Coryne API GLCb Rif, Teic, Vanc  Cip, Ery, F, Gent, Pen, Trim 
C. striatum Case 2 Moist, white, smootha Coryne API Cip, Ery, F, Gent, Rif, 
Trim, Teic, Vanc 
 Pen 
C. jeikeiun Case 3 Gray, nonhemolytica
(aerobic growth)
Coryne API Rif, Teic, Vanc     Cip, Ery, F, Gent, Pen, Trim 
aHorse blood agar at 37°C.
bAPI = analytical profile index; GLC = gas liquid chromatography; Cip = ciprofloxacin; Ery = erythromycin; F = fucidin; Gent = gentamicin; Pen = penicillin; 
Rif = rifampicin; Teic = teicoplanin; Trim = Trimethoprim; Vanc = vancomycin. 